212 related articles for article (PubMed ID: 29756343)
1. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
[TBL] [Abstract][Full Text] [Related]
2. Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.
Teleka S; Jochems SHJ; Häggström C; Wood AM; Järvholm B; Orho-Melander M; Liedberg F; Stocks T
Cancer Med; 2021 Feb; 10(4):1431-1438. PubMed ID: 33455057
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.
Hektoen HH; Robsahm TE; Andreassen BK; Stenehjem JS; Axcrona K; Mondul A; Gislefoss RE
Cancer Med; 2020 Jun; 9(12):4420-4432. PubMed ID: 32319230
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.
Teleka S; Hindy G; Drake I; Poveda A; Melander O; Liedberg F; Orho-Melander M; Stocks T
PLoS One; 2020; 15(11):e0241711. PubMed ID: 33237904
[TBL] [Abstract][Full Text] [Related]
5. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
[TBL] [Abstract][Full Text] [Related]
7. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
[TBL] [Abstract][Full Text] [Related]
8. Metabolic risk score and cancer risk: pooled analysis of seven cohorts.
Stocks T; Bjørge T; Ulmer H; Manjer J; Häggström C; Nagel G; Engeland A; Johansen D; Hallmans G; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
Int J Epidemiol; 2015 Aug; 44(4):1353-63. PubMed ID: 25652574
[TBL] [Abstract][Full Text] [Related]
9. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.
Zitt E; Pscheidt C; Concin H; Kramar R; Lhotta K; Nagel G
PLoS One; 2016; 11(8):e0161376. PubMed ID: 27537361
[TBL] [Abstract][Full Text] [Related]
10. Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project.
Nagel G; Bjørge T; Jaensch A; Peter RS; Häggström C; Lang A; Engeland A; Teleka S; Jirström K; Lindquist D; Stattin P; Ulmer H; Concin H; Stocks T
Int J Cancer; 2021 Jul; 149(1):66-74. PubMed ID: 33634882
[TBL] [Abstract][Full Text] [Related]
11. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
Strohmaier S; Edlinger M; Manjer J; Stocks T; Bjørge T; Borena W; Häggström C; Engeland A; Nagel G; Almquist M; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
PLoS One; 2013; 8(1):e54242. PubMed ID: 23372693
[TBL] [Abstract][Full Text] [Related]
12. Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort.
Holme I; Tonstad S
Eur J Prev Cardiol; 2013 Feb; 20(1):168-75. PubMed ID: 22131130
[TBL] [Abstract][Full Text] [Related]
13. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.
Pscheidt C; Nagel G; Zitt E; Kramar R; Concin H; Lhotta K
PLoS One; 2015; 10(8):e0135052. PubMed ID: 26322515
[TBL] [Abstract][Full Text] [Related]
14. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.
Borena W; Edlinger M; Bjørge T; Häggström C; Lindkvist B; Nagel G; Engeland A; Stocks T; Strohmaier S; Manjer J; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
PLoS One; 2014; 9(2):e89368. PubMed ID: 24586723
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women.
Holick CN; Giovannucci EL; Stampfer MJ; Michaud DS
Int J Cancer; 2007 Jan; 120(1):140-6. PubMed ID: 17036323
[TBL] [Abstract][Full Text] [Related]
16. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
Evers J; Grotenhuis AJ; Aben KKH; Kiemeney LALM; Vrieling A
PLoS One; 2020; 15(3):e0229384. PubMed ID: 32210471
[TBL] [Abstract][Full Text] [Related]
17. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
18. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
[TBL] [Abstract][Full Text] [Related]
19. Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants Study.
Jochems SHJ; Reulen RC; van Osch FHM; Witlox WJA; Goossens ME; Brinkman M; Giles GG; Milne RL; van den Brandt PA; White E; Weiderpass E; Huybrechts I; Hémon B; Agudo A; Bueno-de-Mesquita B; Cheng KK; van Schooten FJ; Bryan RT; Wesselius A; Zeegers MP
Int J Cancer; 2020 Oct; 147(8):2091-2100. PubMed ID: 32285440
[TBL] [Abstract][Full Text] [Related]
20. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
